Skip to main content
Back to 5Y Capital

5Y Capital's Therapeutics Portfolio

Browse 6 Therapeutics companies funded by 5Y Capital. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
6
Total Funding in Therapeutics
$185.0M

Therapeutics Portfolio Companies (6)

Export
Alternative MedicineArtificial Intelligence (AI)BiotechnologyGeneticsTherapeutics

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Brisbane, United States
April 2026
Corporate Round

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Wangli Technology is a digital therapy technology platform for mental illness.

Beijing, China
March 2026
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyTherapeutics

Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs.

Shenzhen, China
January 2026
$11.5M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

Therapeutics

Excalipoint Therapeutics is a Private limited company.

Admiralty, Hong Kong
August 2025
$41.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsTherapeutics

Simaixu Biotechnology is a biopharmaceutical firm that develop small molecule drugs for cancer, and chronic diseases with new technologies

Suzhou, China
July 2025
$1.6M
Series Unknown

Founder Contacts

19,000+ verified contacts

Explore 5Y Capital's Full Portfolio

View all companies funded by 5Y Capital across every industry and funding stage.

View Full 5Y Capital Portfolio